日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy and Safety of Upadacitinib versus Dupilumab Treatment for Moderate-to-Severe Atopic Dermatitis in Four Body Regions: Analysis from the Heads Up Study

乌帕替尼与度普利尤单抗治疗中重度特应性皮炎在四个身体区域的疗效和安全性比较:来自 HEAD UP 研究的分析

Thyssen, Jacob P; Rosmarin, David; Costanzo, Antonio; Warren, Richard; Chu, Chia-Yu; Chovatiya, Raj; Ladizinski, Barry; Hu, Xiaofei; Liu, Yingyi; Calimlim, Brian; Nduaka, Chudi; Vigna, Namita; Armstrong, April

A Descriptive, Post Hoc Analysis of Efficacy and Safety of Risankizumab in Diverse Racial and Ethnic Patient Populations With Moderate-to-Severe Psoriasis

对不同种族和民族的中重度银屑病患者群体中利沙珠单抗的疗效和安全性进行描述性事后分析

Alexis, Andrew F; Gooderham, Melinda; Kwatra, Shawn G; Amin, Ahmad; Taylor, Susan; Espaillat, Ramon; Rettig, Trisha; Wu, Tianshuang; Shi, Linyu; Kaldas, Mark I; Dilley, Deanne M; Sinvhal, Ranjeeta; Nduaka, Chudy; Lockshin, Benjamin

Tofacitinib for the Treatment of Ulcerative Colitis: Analysis of Infection Rates from the Ulcerative Colitis Clinical Programme

托法替尼治疗溃疡性结肠炎:溃疡性结肠炎临床项目的感染率分析

Winthrop, Kevin L; Loftus, Edward V; Baumgart, Daniel C; Reinisch, Walter; Nduaka, Chudy I; Lawendy, Nervin; Chan, Gary; Mundayat, Rajiv; Friedman, Gary S; Salese, Leonardo; Thorpe, Andrew J; Su, Chinyu

Tofacitinib, an Oral Janus Kinase Inhibitor: Analysis of Malignancy (Excluding Nonmelanoma Skin Cancer) Events Across the Ulcerative Colitis Clinical Program

托法替尼,一种口服 Janus 激酶抑制剂:溃疡性结肠炎临床项目中恶性肿瘤(不包括非黑色素瘤皮肤癌)事件的分析

Lichtenstein, Gary R; Rogler, Gerhard; Ciorba, Matthew A; Su, Chinyu; Chan, Gary; Pedersen, Ronald D; Lawendy, Nervin; Quirk, Daniel; Nduaka, Chudy I; Thorpe, Andrew J; Panés, Julian

Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial

阿布昔替尼治疗中重度特应性皮炎患者的疗效和安全性:一项随机临床试验

Silverberg, Jonathan I; Simpson, Eric L; Thyssen, Jacob P; Gooderham, Melinda; Chan, Gary; Feeney, Claire; Biswas, Pinaki; Valdez, Hernan; DiBonaventura, Marco; Nduaka, Chudy; Rojo, Ricardo

The Impact of Raising the Bar for Clinical Trials in Ulcerative Colitis

提高溃疡性结肠炎临床试验标准的影响

Sands, Bruce E; Cheifetz, Adam S; Nduaka, Chudy I; Quirk, Daniel; Wang, Wenjin; Maller, Eric; Friedman, Gary S; Su, Chinyu; Higgins, Peter D R

Herpes Zoster and Tofacitinib: Clinical Outcomes and the Risk of Concomitant Therapy

带状疱疹与托法替尼:临床结果及合并用药风险

Winthrop, Kevin L; Curtis, Jeffrey R; Lindsey, Stephen; Tanaka, Yoshiya; Yamaoka, Kunihiro; Valdez, Hernan; Hirose, Tomohiro; Nduaka, Chudy I; Wang, Lisy; Mendelsohn, Alan M; Fan, Haiyun; Chen, Connie; Bananis, Eustratios

The Safety and Immunogenicity of Live Zoster Vaccination in Patients With Rheumatoid Arthritis Before Starting Tofacitinib: A Randomized Phase II Trial

在开始服用托法替尼之前,对类风湿性关节炎患者进行带状疱疹活疫苗接种的安全性和免疫原性:一项随机II期试验

Winthrop, Kevin L; Wouters, Ann G; Choy, Ernest H; Soma, Koshika; Hodge, Jennifer A; Nduaka, Chudy I; Biswas, Pinaki; Needle, Elie; Passador, Sherry; Mojcik, Christopher F; Rigby, William F

Model-Informed Development and Registration of a Once-Daily Regimen of Extended-Release Tofacitinib

基于模型指导的托法替尼缓释制剂每日一次给药方案的开发和注册

Lamba, M; Hutmacher, M M; Furst, D E; Dikranian, A; Dowty, M E; Conrado, D; Stock, T; Nduaka, C; Cook, J; Krishnaswami, S

Therapeutic and Safety Evaluation of Combined Aqueous Extracts of Azadirachta indica and Khaya senegalensis in Chickens Experimentally Infected with Eimeria Oocysts

印楝和非洲桃花心木水提取物联合治疗及安全性评价在实验感染艾美耳球虫卵囊的鸡中的应用

Gotep, J G; Tanko, J T; Forcados, G E; Muraina, I A; Ozele, N; Dogonyaro, B B; Oladipo, O O; Makoshi, M S; Akanbi, O B; Kinjir, H; Samuel, A L; Onyiche, T E; Ochigbo, G O; Aladelokun, O B; Ozoani, H A; Viyoff, V Z; Dapuliga, C C; Atiku, A A; Okewole, P A; Shamaki, D; Ahmed, M S; Nduaka, C I